8-K: Mobiquity Technologies Secures Up to $4 Million Equity Line and $250,000 Private Placement

Mobiquity Technologies, Inc. has entered into a definitive agreement with ClearThink Capital Partners, LLC for an equity line of credit of up to $4 million and a separate $250,000 private placement.

Summary

• Mobiquity Technologies, Inc. (the "Company") entered into an ELOC Purchase Agreement (referred to as "STRATA") with ClearThink Capital Partners, LLC on June 30, 2025.
• Under the STRATA, ClearThink agreed to purchase up to an aggregate of $4,000,000 of the Company's Common Stock from time to time.
• The purchase price for shares under STRATA will be 91% of the three lowest daily Volume Weighted Average Prices (VWAPs) during an eight-trading-day valuation period.
• Each purchase under STRATA will be a minimum of $25,000 and a maximum of the lesser of $1,000,000 or 400% of the average daily trading value over the ten days preceding the Request Notice date.
• As a Commitment Fee, the Company agreed to issue 100,000 restricted shares of Common Stock to ClearThink.
• The STRATA has a maturity date of 24 months from its Commencement Date.
• A beneficial ownership limitation prevents ClearThink from owning more than 9.99% of the Company's outstanding Common Stock.
• Separately, on June 30, 2025, the Company and ClearThink also entered into a Securities Purchase Agreement (SPA) for ClearThink to purchase 250,000 shares of restricted Common Stock for a total of $250,000.
• The first closing of the SPA occurred on the execution date (June 30, 2025) with funding on July 1, 2025, and the second closing is within five days of the initial registration statement filing.

Sentiment

Score: 6

Explanation: While the financing provides much-needed capital and flexibility, the terms involve dilution and a discount to market price. The explicit mention of potential inability to access the full amount introduces a degree of uncertainty. However, securing capital is generally positive for growth-oriented companies.

Positives

• Secured access to up to $4,000,000 in capital through an equity line of credit (STRATA), providing flexible funding.
• Received an immediate capital injection of $250,000 from the Securities Purchase Agreement.
• ClearThink Capital Partners, LLC is restricted from short selling or hedging to establish a net short position, which could mitigate downward pressure on the stock price from their sales.

Negatives

• The purchase price for shares under the STRATA is at a discount (91% of VWAP), leading to dilution for existing shareholders.
• Issuance of 100,000 restricted shares as a Commitment Fee further dilutes existing shareholders.
• The Company explicitly states it may not have access to the full $4,000,000 available under the STRATA, depending on market conditions and compliance with terms.
• The agreement includes various events of default that could terminate the STRATA, such as lapsed registration statements, trading suspensions, delisting, or bankruptcy.
• The Company has indemnified ClearThink, potentially exposing it to future liabilities.

Risks

• Dilution Risk: Future sales of Common Stock under the STRATA and the issuance of the commitment fee shares will dilute the ownership of existing shareholders.
• Market Price Risk: The purchase price is tied to VWAP, meaning shares will be sold at a discount to the prevailing market price, especially if the stock price declines.
• Access to Capital Risk: The Company explicitly states it "may not have access to the full amount available" under the STRATA due to various conditions and limitations.
• Default Risk: The STRATA can terminate upon various events of default, including lapses in registration statements, trading suspensions, delisting, or bankruptcy, which could cut off access to funding.
• Regulatory Compliance Risk: Failure to maintain an effective registration statement for the resale of securities could trigger an event of default.
• Operational Risk: Breaches of representations, warranties, covenants, or other terms could lead to default.
• Liquidity Risk: Inability of the transfer agent to issue shares electronically (DWAC) could be an event of default.

Future Outlook

The Company intends to use the capital from these agreements to support its operations and strategic initiatives, though specific plans are not detailed. The STRATA provides a flexible funding mechanism for the next 24 months, contingent on market conditions and compliance with agreement terms.

Management Comments

• It is possible that we may not have access to the full amount available to us under the STRATA.

Industry Context

This type of equity line of credit (ELOC) or "at-the-market" (ATM) facility is a common financing tool for smaller, publicly traded companies, particularly those that may not have easy access to traditional debt financing or larger equity offerings. It provides flexibility to raise capital over time, often at a discount to market prices, and can be less dilutive than a single large offering if managed carefully. The immediate private placement provides an upfront cash injection.

Comparison to Industry Standards

• The 9% discount (91% of VWAP) for the equity line is within the typical range for such facilities, which often see discounts between 5% and 15% depending on the company's size, liquidity, and perceived risk.
• The 9.99% beneficial ownership limitation is standard to avoid triggering certain regulatory thresholds or shareholder approval requirements.
• The commitment fee of 100,000 restricted shares is a common component of such agreements, compensating the investor for committing capital.
• The terms regarding events of default (e.g., registration statement lapse, trading suspension, bankruptcy) are standard protective clauses for the investor in these types of financing arrangements.
• The restriction on ClearThink from short selling or hedging is a positive clause for the Company, as some similar agreements do not include such explicit prohibitions, potentially leading to more aggressive selling by the investor.

Stakeholder Impact

• Shareholders: Will experience dilution from the issuance of new shares under both the STRATA and the SPA, as well as the commitment fee shares. The value of their existing holdings may be impacted by the discount at which shares are sold. However, access to capital could support company growth and long-term value.
• Company Operations: The capital infusion provides funding for general corporate purposes, potentially enabling strategic initiatives, working capital, or debt repayment.

Next Steps

• The Company will deliver Request Notices to ClearThink Capital Partners, LLC to draw down funds under the STRATA.
• The Company will file a registration statement with the SEC covering the shares of Common Stock issuable under the STRATA.
• The second closing of the Securities Purchase Agreement will occur within five days of the filing of the initial registration statement.

Key Dates

Recommendation

Keywords

Equity Line of Credit, ELOC, STRATA, ClearThink Capital, Capital Raise, Common Stock, Dilution, SEC Filing, 8-K, Financing Agreement, Securities Purchase Agreement, VWAP, Restricted Shares, Corporate Finance